USPTO serial 86278128
ENVISION PHARMA GROUP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 21, 2015
- Examiner
- SAITO, KIM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with ENVISION PHARMA GROUP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Strategic business consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of health economics and outcomes research; Strategic business marketing consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of market access communication strategies; Strategic business consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of medical and scientific publication planning | ACTIVE | Jun 7, 2013 |
| 041 | Strategic educational consulting services for the life sciences, pharmaceutical and bio-pharmaceutical industries in the field of medical education, namely, continuing professional educational courses and meetings for Medical Science Liaisons | ACTIVE | May 20, 2014 |
| 042 | Medical and scientific publication planning in the nature of technical writing for others related to pharmaceutical and bio-pharmaceutical products; Design and implementation of software and technology solutions for the life science, pharmaceutical and bio-pharmaceutical industries, for the purpose of creating, communicating, reporting and auditing of scientific information to be publicly disclosed; Design and implementation of software and technology solutions for the life science, pharmaceutical and bio-pharmaceutical industries, for use in grant programs that manages investigator sponsored research, product requests, funding requests, donation requests, decision process workflow, activity monitoring, and management of contractual obligations | ACTIVE | Jun 7, 2013 |
| 045 | Strategic consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the nature of regulatory compliance consulting in the field of pharmaceutical and bio-pharmaceutical products | ACTIVE | Jun 7, 2013 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ENVISION PHARMA INC.
- Other trademarks owned by ENVISION PHARMA INC.
- Other trademarks owned by ENVISION PHARMA INC.
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named ENVISION PHARMA GROUP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2024 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Dec 17, 2024 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Dec 17, 2024 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Dec 17, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 9, 2024 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jul 21, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Oct 16, 2021 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 16, 2021 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 16, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 7, 2021 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 21, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 13, 2019 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 13, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 7, 2019 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Nov 7, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 7, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 7, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 7, 2019 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 21, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 5, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 27, 2015 | ALIE | ASSIGNED TO LIE | — |
| Mar 8, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 24, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 24, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 15, 2014 | NWAP | NEW APPLICATION ENTERED | — |